NEW YORK, Feb. 20, 2017 /PRNewswire/ -- This Report analyzes the worldwide markets for Clinical Laboratory Services in US$ Million by the following Segments: Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.
The report profiles 131 companies including many key and niche players such as:
- ADICON Clinical Laboratories, Inc.
- ARUP Laboratories
- Bio-Reference Laboratories, Inc.
- Bioscientia Institut für Medizinische Diagnostik GmbH
- DaVita, Inc.
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1 Disclaimers.............. I-2 Data Interpretation & Reporting Level I-2 Quantitative Techniques & Analytics I-3 Product Definitions and Scope of Study I-3 Hospital-Based Medical Laboratories I-3 Independent Laboratories..............I-4 Physician Office-Based Laboratories I-4
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW.............. II-1 Outlook.............. II-1 Developed Nations: Cost Pressures Necessitate New Strategies II-2 Despite Challenges, Emerging Markets Provide Growth Opportunities.............. II-3 Routine Testing Take the Lead; Esoteric Testing Services Drive Growth.............. II-3 Common Routine and Esoteric Tests II-4 Key Market Drivers..............II-4 Growth Contributing Factors in a Gist II-4 Rising Healthcare Needs of Aging Global Population II-5 Table 1: Global Population Statistics for the 65+ Age Group (2015) (includes corresponding Graph/Chart) II-6
Table 2: Comparison of Aging Population by Country (1980, 2015 & 2050): Percentage Share of Population Aged Above-65 Years of the Overall Population for Select Countries (includes corresponding Graph/Chart) II-7
Table 3: Life Expectancy for Select Countries in Number of Years: 2015E (includes corresponding Graph/Chart) II-8 Increase in Healthcare Spending in Emerging Markets II-9 Table 4: Healthcare Spending as a Percentage of GDP by Region (2016E) (includes corresponding Graph/Chart) II-10
Table 5: Per-Capita Healthcare Expenditure in US$ for Select Countries/Regions (2014) (includes corresponding Graph/Chart).............. II-10 Increasing Awareness Levels..............II-11 Need to Cut Healthcare Costs..............II-11 Rising Incidence of Diseases..............II-11 Major Causes of Fatalities Worldwide II-11 Table 6: Fatalities in High Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD, Cancer, Injury, and Others (includes corresponding Graph/Chart) II-11
Table 7: Fatalities in Mid Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).............. II-12
Table 8: Fatalities in Low Income Countries by Health Disorder (2015 & 2030): Projected Percentage Breakdown of Number of Deaths for CVD; Cancer; Injury; HIV, TB & Malaria; Malnutrition; and Others (includes corresponding Graph/Chart).............. II-13 World Cancer Statistics: Incidence and Mortality Data II-14 Table 9: World Cancer Incidence by Geographic Region and Gender (2012): Number of New Cancer Cases Reported (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).............. II-14
Table 10: World Cancer Mortality by Geographic Region and Gender (2012): Number of Cancer-Related Deaths (in Thousands) for Asia-Oceania, Europe, North America, Latin America & the Caribbean, and Africa (includes corresponding Graph/Chart).............. II-15
Table 11: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart) II-16
Table 12: Global Incidence of Common Cancers in Men (2012): Number of New Cases Reported in Thousands for Lung & Bronchus, Prostate, Colorectal and Liver Cancers (includes corresponding Graph/Chart)..............II-16
Table 13: Global Incidence of Common Cancers in Women (2012): Number of New Cases Reported in Thousands for Breast, Colorectal, Lung & Bronchus and Liver Cancers (includes corresponding Graph/Chart) II-17
Table 14: Global Cancer Mortality in Men for Select Cancers (2012): Number of Deaths in Thousands for Lung & Bronchus, Liver, Colorectal and Prostate Cancers (includes corresponding Graph/Chart)..............II-17
Table 15: Global Cancer Mortality in Women for Select Cancers (2012): Number of Deaths in Thousands for Breast, Lung & Bronchus, Colorectal and Liver (includes corresponding Graph/Chart)..............II-18 Cancer Prone Sites based on Age II-18 Global HIV Statistics..............II-18 Table 16: HIV Infection Statistics Worldwide: As of 2014 (includes corresponding Graph/Chart) II-18
Table 17: Worldwide HIV Prevalence and Incidence (in Million) by Region: 2014 (includes corresponding Graph/Chart).............. II-19
Table 18: Worldwide AIDS Related Deaths by Geographic Region: 2014 (includes corresponding Graph/Chart) II-20
Table 19: HIV-Positive Individuals, by Gender (2014): Percentage Breakdown of Women and Men Tested HIV-Positive in all WHO Regions (includes corresponding Graph/Chart) II-20 Cardiovascular Disease Statistics II-21 Table 20: Fatalities by Heart Conditions - Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others (includes corresponding Graph/Chart).............. II-21
Table 21: Prevalence of Heart Failure in Select Countries (includes corresponding Graph/Chart) II-21
Table 22: Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025, and 2030 (includes corresponding Graph/Chart).............. II-22 Increasing Role of Clinical Labs in Testing of Infectious Diseases.............. II-22
2. MARKET TRENDS & ISSUES..............II-24 IVD Market Growth: An Indication of Growth in Clinical Labs Market.............. II-24 New Technologies and Tests Drive Demand for Specific Testing II-24 Increasing Role of Advanced Tests in Clinical Treatment Decision Making.............. II-24 Increasing Opportunities in Personalized Medicine and Clinical Trial Services.............. II-25 Cancer Testing Market: Opportunity for Clinical Labs II-25 Shortened Hospitalization Enhances Significance of Medical Labs II-26 Lab Automation Speeds Up..............II-26 Standardization Gains Precedence in the Hunt for Automation II-26 Heightened Use of IT Systems in Clinical Laboratories II-27 Assessing the Impact of Point-of-Care Testing on Clinical Labs II-27 Autoimmune Disease Testing: Labs Seek Cost-Effective & High Productivity Options..............II-28 POLs: Reducing Turnaround Times for Testing II-29 POL Market Succumbs to Cost Pressures II-29 Laboratory Outsourcing Trend Gains Strength II-30 Value-Based Outsourcing of Services to Take Centerstage II-30 Challenges Facing Lab Testing Market II-31
3. COMPETITIVE LANDSCAPE..............II-32 A Preview.............. II-32 Quest Diagnostics & LabCorp: The Leading Independent Labs II-32 Consolidation Activity Continues to Soar II-33 Select Major Clinical Laboratory Transactions: 2015 & 2016 II-34 Industry Giants Tread on Different Paths in Consolidation Activity.............. II-35
4. CLINICAL LABORATORY SERVICES - AN INTRODUCTION II-37 Clinical Laboratory Services..............II-37 What is a Medical Laboratory? II-37 Laboratory Medicine.............. II-37 Anatomic Pathology.............. II-38 Clinical Pathology.............. II-38 Types of Tests Conducted in Medical Labs II-40 Routine Tests.............. II-40 Esoteric Tests.............. II-40 Anatomic Pathology Services..............II-41 Types of Clinical Laboratories II-41 Hospital-Based Laboratories..............II-41 Physician Office-Based Laboratories II-41 Reference Laboratories..............II-42 Potential Customers for Medical Laboratories II-42 Work Process in Clinical Labs II-43 Specimen Processing & Result Analysis in Clinical Labs II-43 Laboratory Information Systems II-43 Conducting Lab Tests..............II-43 Key Personnel in Medical Labs..............II-44 Role of Medical Technologists II-44 Role of Medical Technicians II-45 Analysis, Validation and Interpretation of Results II-45 Testing Equipment.............. II-45 Bio-Safety Hazards and Equipment Design II-46 Essential Bio-safety Equipment in Clinical Laboratories II-46 Personal Protection Equipment in Medical Labs II-47 Economic Model Followed By Testing Laboratories II-47 Revenues.............. II-47 Expenses.............. II-47 Dichotomy between Customers and Payers in Medical Lab Industry II-47 Impact of Environmental Factors on Lab Tests II-48 Regulatory Overview.............. II-49 Legislative & Regulatory Environment Worldwide II-49 GCLP.............. II-49 ISO 15189:2003.............. II-49 ISO 15189 Accreditation..............II-49 ILAC.............. II-50
5. SERVICE/PRODUCT INTRODUCTIONS..............II-51 Quest Diagnostics Introduces Antibody Test for Zika Virus II-51 Mayo Clinic Launches Zika Antibody Test II-51 Quest Diagnostics Introduces CogniSense™ Cognitive Assessment Tool.............. II-51 Great Basin Scientific Launches Shiga Toxin Direct Test II-51 Laboratory Corporation of America Launches Zika Virus Testing II-51 Quest Diagnostics Introduces New Cancer Test Services II-51 Laboratory Corporation of America Launches Epi proColon® Colorectal Cancer Test..............II-52 Immunetics to Launch New Services for Invasive Fungal Infections II-52 Unilabs Launches Zika Virus Test II-52 NeoGenomics Adds Two New Tests to its Biopsy Testing Menu II-52 Quest Diagnostics Launches New Test for NSCLC II-52 MDxHealth Introduces SelectMDx™ Test for Prostate Cancer II-52 NeoGenomics Expands its FISG Testing Repertoire with NeoSITE™ II-52 Commonwealth Laboratories Launches IBSchek Blood Test for IBS II-53 Mayo Clinic Introduces New Genetic Testing Panels for Cardiac Diseases.............. II-53 OPKO Unveils 4Kscore® Blood Test for Prostate Cancer II-53 ARUP Laboratories Launches NGS.Web Sequencing Platform II-53 Quest Diagnostics Launches BRCAvantage Plus Services Suite for Breast Cancer.............. II-53 ARUP Laboratories to Offer HLA Genotyping Tests II-53 Quest Diagnostics Launches New Testing Services for Epilepsy Diagnosis.............. II-53
6. RECENT INDUSTRY ACTIVITY..............II-54 Sysmex Inks Agreement with Myanmar's NHL for Improving Clinical Testing.............. II-54 BioPharma Services Acquires Assays from Bioanalytical Laboratory Services..............II-54 Quest Diagnostics Joins Hands with AncestryDNA for Genotyping Test Services.............. II-54 LabCorp Inks Definitive Deal to Acquire and Merge with Sequenom II-54 MDxHealth and Cerba Ink European Distribution Deal for MDxHealth's Prostate Cancer Test II-54 Schryver Medical Takes Over Professional Clinical Laboratory II-54 Oxford Immunotec Inks Definitive Deal to Acquire Imugen II-54 Zora Biosciences and Mayo Medical Team Up for New Plasma Ceramide Tests.............. II-55 Quest Diagnostics Introduces New Hepatitis C Testing Capabilities II-55 Aurora Diagnostics Takes Over Pacific Pathology II-55 Meridian Bioscience Acquires Magellan Biosciences and Magellan Diagnostics.............. II-55 Laboratory Corporation of America Acquires Pathology II-55 Clinical Research Laboratories Takes Over Suncare Research Laboratories.............. II-55 NeoGenomics Acquires Clarient..............II-55 North Shore-LIJ and OPKO Form Alliance for Genetic Testing Services.............. II-56 Quest Diagnostics Acquires Clinical Laboratory Partners's Lab Services Business..............II-56 Medytox to Merge with CollabRx II-56 OPKO Health Expands Genetic Test Offerings at GeneDx II-56 Cinven Acquires Synlab..............II-56 ARUP Secures Group Purchasing Agreement from Novation II-56 NeoGenomics Inks Group Purchasing Deal with Premier II-56 OPKO Health Acquires Bio-Reference Laboratories II-57 BioScience Acquires Select Pharma Laboratories II-57 Exosome Diagnostics Introduces CLIA-Certified Lab in Cambridge II-57 Cinven Acquires Labco..............II-57 Quest Diagnostics Acquires Laboratory Outreach Service Business of MemorialCare Health System II-57 Healthscope Sells Australian Pathology Business II-57 Sonic Healthcare to Take Over Medisupport II-57 Eurofins Acquires Boston Heart Diagnostic II-58 ARUP Laboratories and Labceutics Team Up for Superior Commercial Testing Services..............II-58 TriCore Merges with Rhodes..............II-58 Mérieux NutriSciences Takes Over ABC Research II-58 Unilabs Commences Managed Service Offerings to BMI Ross Hall Hospital.............. II-58 Laboratory Corporation of America Acquires Covance II-58 Thyrocare Technologies Establishes Cytogenetics Division II-58 Laboratory Corporation of America Acquires Bode Technology II-58 ARUP Laboratories Inks Partnership with PierianDx for Developing Improved Genetic Tests II-59 Charles River Laboratories Acquires ChanTest II-59 Alpha Medical Acquires Euromedic's Czech Laboratory II-59 Eurofins Scientific Inks Definitive Agreement to Take Over ViraCor-IBT Laboratories..............II-59 Myriad Genetics Inks Contract with United Healthcare for myRisk™ Test.............. II-59 Quest Diagnostics Acquires Outstanding Stake in Steward's Outreach Laboratory Service Operations II-59 Quest Diagnostics Takes Over Summit Health II-59 LifeLabs and Contextual Genomics Ink Co-Marketing Deal for New Cancer Tests.............. II-60 UCLA, University of California and Centre Testing International Team Up for a New Lab in China II-60 Quest Diagnostics Acquires Solstas Lab Partners II-60 LifeLabs Acquires Centogene's Canadian Business II-60 ACM Medical Laboratory Takes Over Phoenix PCS II-60 Gamma-Dynacare Acquires Lab Bio-Medic II-60
7. FOCUS ON SELECT PLAYERS..............II-61 ADICON Clinical Laboratories, Inc. (China) II-61 ARUP Laboratories (US)..............II-61 Bio-Reference Laboratories, Inc. (US) II-61 Bioscientia Institut für Medizinische Diagnostik GmbH (Germany) II-62 DaVita, Inc. (US).............. II-62 Dynacare (Canada).............. II-62 Enzo Clinical Labs (US)..............II-63 Genoptix Medical Laboratory (US) II-63 Genova Diagnostics, Inc. (US)..............II-64 Kingmed Diagnostics (China)..............II-64 Laboratory Corporation of America Holdings (US) II-65 Mayo Medical Laboratories (US) II-65 NeoGenomics Laboratories (US)..............II-66 Quest Diagnostics, Inc. (US)..............II-66 Sonic Healthcare Limited (Australia) II-67 American Esoteric Laboratories (US) II-67 Spectra Laboratories, Inc. (US)..............II-67 SYNLAB Group (Germany)..............II-68 The National Health Laboratory Service (South Africa) II-68 Thyrocare Technologies Limited (India) II-68 Unilabs SA (Switzerland)..............II-69
8. GLOBAL MARKET PERSPECTIVE..............II-70 Table 23: World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-70
Table 24: World Historic Review for Clinical Laboratory Services by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-71
Table 25: World 14-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-72
Table 26: World Recent Past, Current and Future Analysis for Hospital-Based Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-73
Table 27: World Historic Review for Hospital-Based Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-74
Table 28: World 14-Year Perspective for Hospital-Based Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-75
Table 29: World Recent Past, Current and Future Analysis for Independent Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-76
Table 30: World Historic Review for Independent Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-77
Table 31: World 14-Year Perspective for Independent Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-78
Table 32: World Recent Past, Current and Future Analysis for Physician Office-Based Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............II-79
Table 33: World Historic Review for Physician Office-Based Laboratories by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart).............. II-80
Table 34: World 14-Year Perspective for Physician Office-Based Laboratories by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) II-81
III. MARKET
1. THE UNITED STATES.............. III-1 A.Market Analysis.............. III-1 Clinical Laboratories: A Small Yet Vital Constituent of Healthcare Industry..............III-1 Changing Healthcare Industry Dynamics Affect Clinical Lab Testing Market.............. III-1 Table 35: Healthcare Spending as a % of GDP: 2001-2014 (includes corresponding Graph/Chart) III-2 Positive Outlook for Clinical Laboratory Services Market III-3 Current and Future Analysis III-4 A Glance at Major Growth Drivers III-5 Unmet Diagnostic Needs of Aging Population III-5 Table 36: North American Elderly Population by Age Group (1975-2050) (includes corresponding Graph/Chart) III-6 Increasing Burden of Chronic Diseases Drives Focus onto Early Detection & Prevention III-7 Cancer Statistics in the US..............III-7 Table 37: New Cancer Cases by Gender and Affected Site in the US (2015) (includes corresponding Graph/Chart) III-8 Prevalence of Diabetes Mellitus in North America III-9 Table 38: Prevalence of Diabetes Mellitus in North America (2012) (includes corresponding Graph/Chart) III-9 Opportunities in Personalized Medicine and Clinical Trial Services.............. III-9 Growing Focus on Early Diagnosis III-10 Impact of Scientific Advances & Role of Healthcare IT Solutions.............. III-10 Need to Reduce Healthcare Costs III-10 Legislative, Regulatory and Policy Environment III-11 Opportunities for Individual Testing III-11 Population Screening Initiatives III-11 Challenges Facing Clinical Labs Market III-11 Key Trends & Issues..............III-12 Product-Related Trends..............III-12 Anatomic Pathology & Cytology Testing: Personalized Medicine Presents Positive Future III-13 Esoteric Testing Market: Faster Growth than Routine Testing Segment.............. III-13 Molecular Diagnostics: Promising Growth Opportunities III-14 Drugs of Abuse Testing: Prospects Linked to Employment Levels III-15 Future Holds Promise for Specialty Testing Market III-15 Impact of Healthcare Spending Cuts on Routine & Specialty Lab Tests.............. III-15 Increasing Role of Advanced Tests in Clinical Treatment Decision Making.............. III-15 Tissue-based Diagnostics Market to Expand III-16 Toxicology Laboratories Market: An Insight III-16 Genetic and Genomic Clinical Lab Testing Market: Promising Prospects.............. III-16 Shift towards Managed Care - A Challenge for Independent Clinical Labs?..............III-18 Evolving ACO Business Model: A Challenge for Independent Labs III-18 Integration of Clinical Care: Impact on Clinical Labs & Anatomic Pathology Groups..............III-19 Hospital Laboratory Outreach Programs: On the Rise III-19 Physician Practices: The New Acquisition Targets III-20 Table 39: % of Independent Physicians in the US (2000, 2005 & 2016) (includes corresponding Graph/Chart) III-21 Cost Cutting Measures to Hit Lab Outreach Testing Business? III-21 Hospitals Foray into Health Insurance Market: Opportunities for Hospital Labs..............III-21 Shortened Hospital Stay Enhances Significance of Medical Labs III-22 Lab Automation: A Key Trend in the Clinical Laboratory Testing Market..............III-22 Health Plans Interpose Between Clinical Labs and Physicians III-22 POCT Segment Withstands Cost Pressures III-22 Quality Concerns Bring Information Technologies to the Fore III-23 Move towards IQCP Remains Lethargic III-23 Dealing with Regulatory Changes: A Tough Ask for Clinical Labs III-23 A Peek into Reimbursement Environment for Clinical Lab Services.............. III-24 Regulation of LDTs Hangs in Balance III-25 Competitive Landscape..............III-25 Providers of Clinical Laboratory Service in the US: A Review III-26 Hospital-Based Labs..............III-26 Table 40: Registered Hospitals in the US by Type: 2017 (includes corresponding Graph/Chart) III-27 Independent Labs..............III-27 Table 41: Independent Labs Market in the US (2016E): Percentage Share Breakdown of Revenues for LabCorp, Quest Diagnostics, Small Independent Labs and Others (includes corresponding Graph/Chart)..............III-28 Physician Office-Based Labs and Others III-28 Consolidation Activity Gathers Pace in Clinical Laboratory Testing Market..............III-29 Table 42: Number of Closed M&A Transactions in the US Clinical Labs Market (2005-2013) (includes corresponding Graph/Chart).............. III-30
Table 43: Closed M&A Transactions in the US Clinical Labs Market (2009-2013): Breakdown by Clinical Labs and Anatomic Pathology & Specialty Labs (includes corresponding Graph/Chart) III-30 Regulatory Landscape..............III-31 Select Major Regulations..............III-31 A2LA.............. III-31 ASCLS.............. III-31 CAP.............. III-31 Clinical Laboratory Improvement Amendments (CLIA) III-32 Table 44: CLIA-Certified Laboratories in the US (2015): Percentage Share Breakdown of Number of Laboratories by Certificate Type (includes corresponding Graph/Chart) III-33
Table 45: CLIA-Certified Laboratories in the US (2016): Percentage Share Breakdown of Number of Labs by Lab Type (includes corresponding Graph/Chart) III-34 PAMA to have A Major Impact on Impact Clinical Laboratory Market.............. III-34 Health Insurance Portability and Accountability Act of 1996 III-35 FDA Regulations..............III-35 Substance Abuse and Mental Health Services Administration (SAMHSA) Regulation..............III-35 Medicare Coverage for Screening Tests III-35 Medicare Clinical Laboratory Fee Schedule (CLFS) III-36 Medicare Physician Fee Schedule (MPFS) III-37 Medicaid.............. III-37 Table 46: Medicare Spending in the US (2015): Percentage Share Breakdown of Spending by Category - Inpatient Hospital, Medicare Advantage, Outpatient Hospital, Physician Fee Schedule, Prescription Drugs and Others (includes corresponding Graph/Chart) III-37 Service Launches..............III-38 Strategic Corporate Developments III-40 Key Players.............. III-45 B.Market Analytics..............III-51 Table 47: US Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-51
Table 48: US Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-52
Table 49: US 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-53
2. CANADA.............. III-54 A.Market Analysis.............. III-54 Outlook.............. III-54 Rising Incidence of Chronic Diseases Spurs Need for Testing III-54 Table 50: New Cancer Cases in Canada (2016): Percentage Breakdown of Cancer Incidence by Gender and Affected Site (includes corresponding Graph/Chart) III-55
Table 51: New Cancer Cases in Canada by Province (2016) (includes corresponding Graph/Chart) III-56
Table 52: Cancer Incidence in Canada by Age Group and Gender: Age Standardized Incidence Rate per 100,000 People (2015) (includes corresponding Graph/Chart) III-57 Regulatory Scenario in Canada..............III-57 Accreditation Canada..............III-57 Standards Council of Canada III-59 Strategic Corporate Developments III-60 Dynacare - A Key Player..............III-61 B.Market Analytics..............III-62 Table 53: Canadian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-62
Table 54: Canadian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-63
Table 55: Canadian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-64
3. JAPAN.............. III-65 A.Market Analysis.............. III-65 Outlook.............. III-65 Physician Office Labs Play Limited Role in Lab Services III-65 Demographics Drive Market Growth III-65 Table 56: Percentage Distribution of Japanese Population by Age Group: 2015 (includes corresponding Graph/Chart) III-66 Table 57: Prevalence of Diabetes Mellitus in Japan (2012 & 2030) (includes corresponding Graph/Chart) III-66 B.Market Analytics..............III-67 Table 58: Japanese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-67
Table 59: Japanese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-68
Table 60: Japanese 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-69
4. EUROPE.............. III-70 A.Market Analysis.............. III-70 Outlook.............. III-70 Table 61: Diagnostics Market in Europe (2016E): Percentage Share Breakdown of Revenues by Medical Imaging, Laboratory Testing, and Anatomic Pathology (includes corresponding Graph/Chart).............. III-70 European Healthcare System: In a State of Transition? III-71 Aging Population to Drive Demand for Medical Laboratory Services.............. III-71 Table 62: Population Breakup by Age Group for EU-28 Countries: 2015 (As a Percentage of Total Population) (includes corresponding Graph/Chart) III-72 A Peek into the Competitive Landscape III-73 Select Leading Players..............III-73 Synlab-Labco Combination Alters Market Landscape III-74 Accreditation and Regulatory Scenario in the EU III-74 B.Market Analytics..............III-75 Table 63: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart)..............III-75
Table 64: European Historic Review for Clinical Laboratory Services by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-76
Table 65: European 14-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-77
Table 66: European Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-78
Table 67: European Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-79
Table 68: European 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-80
4a. FRANCE.............. III-81 A.Market Analysis.............. III-81 Outlook.............. III-81 Market Overview.............. III-81 Table 69: Percentage Distribution of French Population by Age Group: 2015 (includes corresponding Graph/Chart) III-81 Complex Regulations Slow Down Industry Consolidation III-82 Table 70: Leading Players in the French Clinical Laboratory Services Market (2015): Percentage Breakdown of Revenues for Cerba/Novescia, Eurofins, Labco, Unilabs and Others (includes corresponding Graph/Chart) III-82 Strategic Corporate Development III-82 B.Market Analytics..............III-83 Table 71: French Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-83
Table 72: French Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-84
Table 73: French 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-85
4b. GERMANY.............. III-86 A.Market Analysis.............. III-86 Outlook.............. III-86 Physician Office Lab Market Fails to Gather Momentum III-86 Privatization: A Visible Trend in the Labs Market III-86 Regulatory Scenario in Germany III-87 DAkkS GmbH - Germany's National Accreditation Body III-87 Strategic Corporate Development III-87 Key Players.............. III-87 B.Market Analytics..............III-88 Table 74: German Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-88
Table 75: German Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-89
Table 76: German 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-90
4c. ITALY.............. III-91 A.Market Analysis.............. III-91 Outlook.............. III-91 ACCREDIA - The Italian Accreditation Body III-91 B.Market Analytics..............III-92 Table 77: Italian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-92
Table 78: Italian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-93
Table 79: Italian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-94
4d. THE UNITED KINGDOM..............III-95 A.Market Analysis.............. III-95 Outlook.............. III-95 UKAS - The Sole National Accreditation Body in the UK III-95 Strategic Corporate Developments III-96 B.Market Analytics..............III-97 Table 80: UK Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-97
Table 81: UK Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-98
Table 82: UK 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart) III-99
4e. SPAIN.............. III-100 Market Analysis.............. III-100 Table 83: Spanish Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-100
Table 84: Spanish Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-101
Table 85: Spanish 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-102
4f. RUSSIA.............. III-103 Market Analysis.............. III-103 Table 86: Russian Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-103
Table 87: Russian Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-104
Table 88: Russian 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-105
4g. REST OF EUROPE.............. III-106 A.Market Analysis.............. III-106 Outlook.............. III-106 Focus on Select Regional Markets III-106 Switzerland.............. III-106 Overview.............. III-106 Physician Office Labs Market Goes Strong in Swiss III-106 Poland.............. III-107 Ukraine.............. III-107 Service Launches..............III-107 Strategic Corporate Developments III-107 Unilabs Sa (Switzerland) - A Key Player III-108 B.Market Analytics..............III-109 Table 89: Rest of Europe Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-109
Table 90: Rest of Europe Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-110
Table 91: Rest of Europe 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-111
5. ASIA-PACIFIC.............. III-112 A.Market Analysis.............. III-112 Overview.............. III-112 Healthcare Spending in Asia-Pacific: On the Rise III-112 China and India: Two Fast-Growing Markets III-113 APLAC - A Regional Accreditation Body in Asia-Pacific III-113 B.Market Analytics..............III-114 Table 92: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart).............. III-114
Table 93: Asia-Pacific Historic Review for Clinical Laboratory Services by Geographic Region - China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-115
Table 94: Asia-Pacific 14-Year Perspective for Clinical Laboratory Services by Geographic Region - Percentage Breakdown of Revenues for China and Rest of Asia-Pacific Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-116
Table 95: Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-117
Table 96: Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-118
Table 97: Asia-Pacific 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-119
5a. CHINA.............. III-120 A.Market Analysis.............. III-120 Outlook.............. III-120 Medical Labs Market: An Overview III-120 Healthcare Reforms: Opportunities for Clinical Labs Market III-120 Drive to Improve Access to Healthcare Fuels Growth in Independent Clinical Laboratories III-121 Table 98: Leading Independent Medical Labs in China (2015): Percentage Breakdown of Revenues for Adicon Clinical Laboratories, DiAn Diagnostics, KingMed Diagnostics and Others (includes corresponding Graph/Chart) III-122 Industry Leaders Look to Expand Beyond Clinical Services III-123 CNAL - The National Accreditation Body in China III-123 HKAS - An Accreditation Body in Hong Kong III-124 Strategic Corporate Development III-124 Key Players.............. III-125 B.Market Analytics..............III-126 Table 99: Chinese Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-126
Table 100: Chinese Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-127
Table 101: Chinese 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-128
5b. REST OF ASIA-PACIFIC..............III-129 A.Market Analysis.............. III-129 Outlook.............. III-129 Review of Select Regional Markets III-129 Australia.............. III-129 NATA - An Australian Regulatory Agency III-129 India.............. III-130 Clinical Laboratory Market: Overview III-130 Growth Drivers..............III-131 Challenges.............. III-131 Biochemistry Analysis: An Important Clinical Lab Segment III-132 Table 102: Indian Clinical Laboratory Market (2016E): Percentage Share Breakdown of Revenues by Segment - Biochemistry, Immunology, Hematology, Microbiology, Histopathology, Molecular, and Genetics (includes corresponding Graph/Chart)..............III-132 Competitive Landscape..............III-133 Business Model of Medical Labs III-133 Table 103: Indian Medical Laboratories Market (2013)): Number of Labs and Collection Centers Operated by Metropolis, SRL Diagnostics, and Dr. Lal Path Labs III-134 Regulatory Scenario in India III-134 Indonesia.............. III-134 Korea.............. III-135 Rapidly Aging Population Spurs Demand for Clinical Lab Testing.............. III-135 KOLAS - The National Accreditation Agency of Korea III-135 Philippines.............. III-135 Regulatory Scenario in Philippines III-135 Singapore.............. III-136 SAC - The National Agency for Accreditation in Singapore III-136 Thailand.............. III-136 BLQS - A Designated Accreditation Authority in Thailand III-136 Strategic Corporate Developments III-137 Key Players.............. III-137 B.Market Analytics..............III-139 Table 104: Rest of Asia-Pacific Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-139
Table 105: Rest of Asia-Pacific Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-140
Table 106: Rest of Asia-Pacific 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart)..............III-141
6. LATIN AMERICA.............. III-142 A.Market Analysis.............. III-142 Outlook.............. III-142 Brazil.............. III-142 Overview.............. III-142 INMETRO - The National Accreditation Body of Brazil III-142 Chile.............. III-143 Service Launch.............. III-143 B.Market Analytics..............III-144 Table 107: Latin American Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-144
Table 108: Latin American Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-145
Table 109: Latin American 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-146
7. REST OF WORLD.............. III-147 A.Market Analysis.............. III-147 Outlook.............. III-147 Medical Laboratories in Sub-Saharan Africa III-147 East Africa.............. III-147 West Africa.............. III-148 Nigeria.............. III-148 South Africa.............. III-148 Regulatory Environment in South Africa III-148 The National Health Laboratory Service (South Africa) - A Key Player.............. III-149 B.Market Analytics..............III-150 Table 110: Rest of World Recent Past, Current and Future Analysis for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) III-150
Table 111: Rest of World Historic Review for Clinical Laboratory Services by Location - Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) III-151
Table 112: Rest of World 14-Year Perspective for Clinical Laboratory Services by Location - Percentage Breakdown of Revenues for Hospital-Based Laboratories, Independent Laboratories, and Physician Office-Based Laboratories Markets for Years 2009, 2016 & 2022 (includes corresponding Graph/Chart).............. III-152
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 131 (including Divisions/Subsidiaries - 143)
The United States (98) Canada (11) Japan (1) Europe 15) - France (2) - Germany (2) - The United Kingdom (5) - Rest of Europe (6) Asia-Pacific (Excluding Japan) (9) Middle East (4) Africa (5)
Read the full report: http://www.reportlinker.com/p04707129-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article